Psychotropic drugs and the ECG: focus on the QTc interval
- 1 May 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 3 (5) , 479-498
- https://doi.org/10.1517/14656566.3.5.479
Abstract
The QT interval measuring depolarisation and repolarisation has, when lengthened, been implicated as a risk factor for the development of torsades de pointes and sudden death, particularly in patients predisposed to these complications due to cardiovascular impairment. Since some of the medications used in psychiatry have been implicated, an extensive review of available literature was made of the major classes, including antipsychotics, antidepressants, lithium, anticonvulsants and benzodiazepines. Further, where no publications were found on a particular medication, the pharmaceutical firms responsible for these items were contacted concerning possibly unpublished data. Results of the survey indicate that there may be difficulty in one of three situations: immediate (in the first minutes to hours after oral or parenteral administration), short-term use of 4 – 12 weeks or long-term use of ≥ 6 months. Based on this approach, the greatest concern is directed at the immediate application of haloperidol, dro...Keywords
This publication has 24 references indexed in Scilit:
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden DeathAmerican Journal of Psychiatry, 2001
- Association of autonomic dysfunction and clozapineThe British Journal of Psychiatry, 2001
- Psychopharmacology: Cardiac Effects of Antipsychotic MedicationsPsychiatric Services, 2001
- Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmiasExpert Opinion on Pharmacotherapy, 2000
- Torsade De Pointes Resulting from the Addition of Droperidol to an Existing Cytochrome P450 Drug InteractionAnnals of Pharmacotherapy, 1998
- Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humansClinical Pharmacology & Therapeutics, 1996
- Droperidol Causes a Dose-dependent Prolongation of the QT IntervalAnesthesia & Analgesia, 1994
- Prolongation of the Corrected QT and Torsades de Pointes Cardiac Arrhythmia Associated with Intravenous Haloperidol in the Medically IIIJournal of Clinical Psychopharmacology, 1993
- Haloperidol-Induced Torsades de PointesChest, 1990
- Torsades de Pointes Ventricular Tachyarrhythmia Associated with HaloperidolJournal of Clinical Psychopharmacology, 1986